echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > People's Daily: the government still needs to do a lot of work on how to use price reducing drugs for patients as soon as possible

    People's Daily: the government still needs to do a lot of work on how to use price reducing drugs for patients as soon as possible

    • Last Update: 2016-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on May 23, 2016, the people's daily broke the mechanism of supplementing medicine with drugs and cut off the interest transmission chain of medicine, which should also be the proper meaning of drug price reform Visual China data on May 20, the results of the first national drug price negotiation announced that the price of three drugs for the treatment of hepatitis B and lung cancer has been reduced by more than half, which is similar to the surrounding countries It is worth further celebrating that the national drug price negotiation will become the norm, and more drug prices will no longer be "high" Patent drugs and exclusive drugs are lack of market competition and are expensive Many patients can't afford them, but they do work For example, the three drugs in this negotiation are the first-line drugs recommended by who and European and American countries What if I can't afford it? International practice is price negotiation Last year, 16 ministries and commissions formed a coordination group, established a negotiation mechanism, conducted multiple rounds of negotiations with relevant enterprises in accordance with the idea of "one medicine, one policy", and exchanged price for quantity through group purchase, finally forming the above negotiation results With the continuous promotion of national negotiations, more drugs are included in the scope of negotiations, and the beneficiary population is expanding It is of great significance to fully reflect the determination of the country After the negotiation, a lot of follow-up work needs to be done so that patients can use the reduced price drugs as soon as possible One is purchase and distribution, the other is medical insurance payment The two links must be connected, and neither of them is indispensable Purchase needs to determine the quantity first, otherwise there will be a negotiated price, and the enterprise cannot produce or distribute in place But how to determine the amount of drugs used? We need to find a way It is an important weight to include the negotiated drugs in the medical insurance negotiation If only the price is reduced but the medical insurance cannot be used for reimbursement, the drug price is still too high for the vast majority of patients The notice on doing well in national negotiation on centralized purchase of drugs, which was released simultaneously on May 20, made arrangements, but specific implementation measures still need to be issued by each province For example, each province needs to negotiate and determine related matters of online purchase, and the online purchase price can only be determined before the end of June The connection of medical insurance is more complex, and medical insurance is closely related to the financial level of all regions It is necessary to evaluate and calculate drugs, determine compliance costs, and do as you can In addition, there are many types of medical insurance, each with its own directory, which directory to include and how appropriate the reimbursement level need to be determined by each region Negotiation price is a kind of national drug classified procurement and a drug pricing method How to squeeze the drug price water to a greater extent and return to a reasonable level cannot rely on the reform of drug procurement mechanism alone To break the mechanism of supplementing medicine with medicine and cut off the chain of interest transmission of medicine should also be the proper meaning of drug price reform.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.